The supply-side theory has been applied as a fiscal policy by several U.S. presidents to stimulate the economy by targeting factors that increase output and supply more goods and services.
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the immediate impact Spravato has had on patients with treatment-resistant ...
As­traZeneca and Dai­ichi Sankyo’s an­ti­body-drug con­ju­gate En­her­tu is now ap­proved to treat a new sub­set of breast can­cer pa­tients with very low lev­els of HER2 … ...
Eli Lil­ly is dis­con­tin­u­ing a Phase 2 re­lax­in treat­ment can­di­date for heart fail­ure and chron­ic kid­ney dis­ease, a spokesper­son for the com­pa­ny con­firmed to … ...
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the approval of Spravato for treatment-resistant depression. PE: How does ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
For many, the pandemic wasn’t just a health crisis. It marked a turning point where government power grew, society became deeply divided and personal freedoms were stripped away. Australians ...
New drugs like Carvykti, Tecvayli and Spravato also contributed to growth. Xarelto and Simponi/Simponi Aria sales also improved in the quarter. The sales growth was partially dampened by lower ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...
Drug is the first and only approved monotherapy for refractory major depressive disorder. (HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal ...
Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients per week. According to Parkside, these patients are seen at least twice a week for the ...